Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder.

Strawn JR, Wehry AM, DelBello MP, Rynn MA, Strakowski S.

Depress Anxiety. 2012 Apr;29(4):328-39. doi: 10.1002/da.21913. Review.

PMID:
22511364
2.

Psychopharmacologic treatment of children and adolescents with anxiety disorders.

Strawn JR, Sakolsky DJ, Rynn MA.

Child Adolesc Psychiatr Clin N Am. 2012 Jul;21(3):527-39. doi: 10.1016/j.chc.2012.05.003. Epub 2012 May 24. Review.

PMID:
22800992
3.

The functional anatomy, neurochemistry, and pharmacology of anxiety.

Ninan PT.

J Clin Psychiatry. 1999;60 Suppl 22:12-7. Review.

4.

Neurocircuitry of generalized anxiety disorder in adolescents: a pilot functional neuroimaging and functional connectivity study.

Strawn JR, Bitter SM, Weber WA, Chu WJ, Whitsel RM, Adler C, Cerullo MA, Eliassen J, Strakowski SM, DelBello MP.

Depress Anxiety. 2012 Nov;29(11):939-47. doi: 10.1002/da.21961. Epub 2012 May 24.

PMID:
22628125
5.

A preliminary investigation of neural correlates of treatment in adolescents with generalized anxiety disorder.

Maslowsky J, Mogg K, Bradley BP, McClure-Tone E, Ernst M, Pine DS, Monk CS.

J Child Adolesc Psychopharmacol. 2010 Apr;20(2):105-11. doi: 10.1089/cap.2009.0049.

6.

Assessment and treatment of anxiety disorders in children and adolescents.

Wehry AM, Beesdo-Baum K, Hennelly MM, Connolly SD, Strawn JR.

Curr Psychiatry Rep. 2015 Jul;17(7):52. doi: 10.1007/s11920-015-0591-z. Review.

7.

Treatment of generalized anxiety disorder.

Gorman JM.

J Clin Psychiatry. 2002;63 Suppl 8:17-23. Review.

8.

Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder.

Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HM, Chen G, McClure-Tone EB, Ernst M, Pine DS.

Arch Gen Psychiatry. 2008 May;65(5):568-76. doi: 10.1001/archpsyc.65.5.568.

9.

Therapeutic options: Addressing the current dilemma.

Dinan T.

Eur Neuropsychopharmacol. 2006 Jul;16 Suppl 2:S119-27. Epub 2006 May 26. Review.

PMID:
16730164
10.

Pharmacological treatment for generalized anxiety disorder in adults: an update.

Reinhold JA, Rickels K.

Expert Opin Pharmacother. 2015;16(11):1669-81. doi: 10.1517/14656566.2015.1059424. Review.

PMID:
26159446
11.

WCA recommendations for the long-term treatment of generalized anxiety disorder.

Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP; World Council of Anxiety.

CNS Spectr. 2003 Aug;8(8 Suppl 1):53-61. Review.

PMID:
14767398
12.

Selecting pharmacotherapy for generalized anxiety disorder.

Goodman WK.

J Clin Psychiatry. 2004;65 Suppl 13:8-13. Review.

13.

New developments in the neurobiological basis of anxiety disorders.

Gorman JM, Hirschfeld RM, Ninan PT.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:49-67. Review.

PMID:
12490823
14.

Pharmacologic Treatment of Pediatric Anxiety Disorders.

Hussain FS, Dobson ET, Strawn JR.

Curr Treat Options Psychiatry. 2016 Jun;3(2):151-160. Epub 2016 Apr 22.

15.

Current considerations in the treatment of generalized anxiety disorder.

Katzman MA.

CNS Drugs. 2009;23(2):103-20. doi: 10.2165/00023210-200923020-00002. Review.

PMID:
19173371
16.

Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder.

Faria V, Ahs F, Appel L, Linnman C, Bani M, Bettica P, Pich EM, Wahlstedt K, Fredrikson M, Furmark T.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1149-57. doi: 10.1017/S1461145714000352. Epub 2014 Mar 26. Erratum in: Int J Neuropsychopharmacol. 2014 Aug;17(8):1353. Wahlstedt, Kurt [added].

PMID:
24666527
17.

Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy.

Dell'Osso B, Buoli M, Baldwin DS, Altamura AC.

Hum Psychopharmacol. 2010 Jan;25(1):17-29. doi: 10.1002/hup.1074. Review.

PMID:
20041476
18.

Neurobiology of Pediatric Anxiety Disorders.

Strawn JR, Dominick KC, Patino LR, Doyle CD, Picard LS, Phan KL.

Curr Behav Neurosci Rep. 2014 Sep 1;1(3):154-160.

19.

fMRI predictors of treatment outcome in pediatric anxiety disorders.

McClure EB, Adler A, Monk CS, Cameron J, Smith S, Nelson EE, Leibenluft E, Ernst M, Pine DS.

Psychopharmacology (Berl). 2007 Mar;191(1):97-105. Epub 2006 Sep 14.

PMID:
16972100
20.

Generalized anxiety disorder: raising the expectations of treatment.

Allgulander C, Sheehan DV.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:68-78. Review.

PMID:
17450651

Supplemental Content

Support Center